Harvard Researchers Develop Blood Test for Early Detection of Alzheimer’s Disease
A Harvard-affiliated research team at Mass General Brigham has discovered that a blood test measuring plasma phosphorylated tau 217 (pTau217) could forecast Alzheimer’s disease progression long before symptoms or brain scan changes occur. This finding, published in Nature Communications, suggests this test could simplify disease prediction and identify those at risk of cognitive decline. Lead…
